What is NDC 63187-510?

63187-510 is the product NDC for Lansoprazole, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.

Proficient Rx LP, NDC labeler code 63187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lansoprazole?

94 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lansoprazole NDC 63187-510 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-510Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0510Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-510-30	6318705103063187051030	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63187-510-30)Marketed from Jul 1, 2015
63187-510-60	6318705106063187051060	60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63187-510-60)Marketed from Jul 1, 2015
63187-510-90	6318705109063187051090	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (63187-510-90)Marketed from Jul 1, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lansoprazole
Generic name (nonproprietary): lansoprazole
Active ingredients: Lansoprazole — 30 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Proficient Rx LPNDC labeler code 63187
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091269
Marketing start: Oct 15, 2010
Listing expires: Dec 31, 2027
Other FDA classes: Inhibition Gastric Acid Secretion (Physiologic effect)Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 63187-510_06664186-1f92-44f3-b25e-97f1f6a539eaSPL ID 06664186-1f92-44f3-b25e-97f1f6a539eaSPL set ID 3e3e63df-e2ad-420b-acb9-28e65ea6fb07RxCUI 311277UNII 0K5C5T2QPGUPC 0363187510305
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187051030 followed by a unit qualifier and the quantity

Package 63187-0510-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2022.

Indications (excerpt from the label)

Lansoprazole delayed-release capsule is a proton pump inhibitor (PPI) indicated for: • Short-Term Treatment of Active Duodenal Ulcer ( 1.1 ) • H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence (1.2) • Maintenance of Healed Duodenal Ulcers ( 1.3) • Short-Term Treatment of Active Benign Gastric Ulcer (1.4) • Healing of nonsteroidal anti-inflammatory drugs (NSAID)-Associated Gastric Ulcer ( 1.5 ) • Risk Reduction of NSAID-Associated Gastric Ulcer (1.6) • Gastroesophageal Reflux Disease (GERD) ( 1.7 ) • Maintenance of Healing of Erosive Esophagitis (EE) ( 1.8 ) • Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (ZES) ( 1.9 ) 1.1 Short-Term Treatment…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63187-510

What is NDC 63187-510?: 63187-510 is the product NDC for Lansoprazole, Lansoprazole 30 mg/1 capsule, delayed release, listed with the FDA by Proficient Rx LP. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lansoprazole.
What is the active ingredient?: Lansoprazole.
Who is the labeler?: Proficient Rx LP, NDC labeler code 63187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lansoprazole?: 94 other product NDCs are listed under this name. See all Lansoprazole NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lansoprazole NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lansoprazole	Lansoprazole 30 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Cardinal Health 107, LLC	55154-8340	55154-8340-00
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Preferred Pharmaceuticals Inc.	68788-4141	68788-4141-0368788-4141-0668788-4141-09
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Amazon.com Services LLC	72288-672	72288-0672-55
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Amazon.com Services LLC	72288-827	72288-0827-03
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed release pelletsOral	Safecor Health LLC	48433-051	48433-0051-08
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Medcore LLC	82461-713	82461-0713-30
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-310	33342-0310-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-311	33342-0311-07
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-8621	68788-8621-0168788-8621-0368788-8621-06+2 more
Lansoprazole	Lansoprazole 15 mg/1	Tablet, Orally disintegrating, Delayed releaseOral	Aurobindo Pharma Limited	65862-895	65862-0895-78

All 95 Lansoprazole NDCs

Other NDCs under ANDA 091269

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091269
Product	Strength	Form · route	Labeler	Product NDC
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Redpharm Drug	67296-2270
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Dr.Reddy's Laboratories Ltd.	55111-398
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Dr.Reddy's Laboratories Ltd.	55111-399
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-2957
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Bryant Ranch Prepack	71335-0058
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	Major Pharmaceuticals	0904-6662
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Preferred Pharmaceuticals Inc.	68788-6390
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-4456
Lansoprazole DRlansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	Advanced Rx Pharmacy of Tennessee, LLC	80425-0148
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	A-S Medication Solutions	50090-6830
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	American Health Packaging	60687-111
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	American Health Packaging	60687-123
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	68071-3687
Lansoprazole	Lansoprazole 15 mg/1	Capsule, Delayed releaseOral	BluePoint Laboratories	68001-111
Lansoprazole	Lansoprazole 30 mg/1	Capsule, Delayed releaseOral	BluePoint Laboratories	68001-112